Eagle Pharmaceuticals Inc (EGRX) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Eagle Pharmaceuticals, Inc. is on the clock to file its overdue quarterly report after receiving a delinquency notice from Nasdaq for not complying with listing rules. They’ve been granted a 180-day extension until May 13, 2024, to submit their financials and avoid delisting. The company’s future on the stock market hangs in the balance as they work to meet the deadline and maintain their listing status.
For further insights into EGRX stock, check out TipRanks’ Stock Analysis page.